Skip to main content

and
  1. No Access

    Article

    Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer

    Many women with hormone receptor-positive breast cancer discontinue effective aromatase inhibitor (AI) treatment due to joint symptoms.

    Heather Greenlee, Katherine D. Crew, Theresa Shao in Supportive Care in Cancer (2013)